These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 24010934)
1. CoMFA, CoMSIA and HQSAR studies of acetylcholinesterase inhibitors. Jiang YR; Yang YY; Chen YL; Liang ZJ Curr Comput Aided Drug Des; 2013 Sep; 9(3):385-95. PubMed ID: 24010934 [TBL] [Abstract][Full Text] [Related]
2. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques. Abdizadeh R; Hadizadeh F; Abdizadeh T Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775 [TBL] [Abstract][Full Text] [Related]
3. Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives. Zhang S; Hou B; Yang H; Zuo Z Arch Pharm Res; 2016 May; 39(5):591-602. PubMed ID: 26832327 [TBL] [Abstract][Full Text] [Related]
4. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors. Chaudhaery SS; Roy KK; Saxena AK J Chem Inf Model; 2009 Jun; 49(6):1590-601. PubMed ID: 19441865 [TBL] [Abstract][Full Text] [Related]
5. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators. Gajjar KA; Gajjar AK Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214 [TBL] [Abstract][Full Text] [Related]
6. Comparative QSAR studies using HQSAR, CoMFA, and CoMSIA methods on cyclic sulfone hydroxyethylamines as BACE1 inhibitors. Zhang S; Lin Z; Pu Y; Zhang Y; Zhang L; Zuo Z Comput Biol Chem; 2017 Apr; 67():38-47. PubMed ID: 28043074 [TBL] [Abstract][Full Text] [Related]
7. QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA. Sainy J; Sharma R SAR QSAR Environ Res; 2015; 26(10):873-92. PubMed ID: 26524489 [TBL] [Abstract][Full Text] [Related]
8. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis. Roy KK; Dixit A; Saxena AK J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163 [TBL] [Abstract][Full Text] [Related]
9. CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of breast cancer. Chhatbar DM; Chaube UJ; Vyas VK; Bhatt HG Comput Biol Chem; 2019 Jun; 80():351-363. PubMed ID: 31085426 [TBL] [Abstract][Full Text] [Related]
10. Molecular docking and 3D-QSAR studies of 2-substituted 1-indanone derivatives as acetylcholinesterase inhibitors. Shen LL; Liu GX; Tang Y Acta Pharmacol Sin; 2007 Dec; 28(12):2053-63. PubMed ID: 18031622 [TBL] [Abstract][Full Text] [Related]
11. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking. Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756 [TBL] [Abstract][Full Text] [Related]
12. QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR. Sridhar J; Foroozesh M; Stevens CL SAR QSAR Environ Res; 2011 Oct; 22(7-8):681-97. PubMed ID: 22004550 [TBL] [Abstract][Full Text] [Related]
13. Modeling study of phenylsulfonylfuroxan derivatives as P-gp inhibitors: a combined approach of CoMFA, CoMSIA and HQSAR. Gadhe CG; Balupuri A; Balasubramanian PK; Cho SJ Anticancer Agents Med Chem; 2014; 14(7):1019-30. PubMed ID: 24066798 [TBL] [Abstract][Full Text] [Related]
14. Pharmacophore based 3DQSAR of phenothiazines as specific human butyrylcholinesterase inhibitors for treatment of Alzheimer's disease. Kundaikar HS; Agre NP; Degani MS Curr Comput Aided Drug Des; 2014; 10(4):335-48. PubMed ID: 25794302 [TBL] [Abstract][Full Text] [Related]
15. 3D QSAR studies of AChE inhibitors based on molecular docking scores and CoMFA. Akula N; Lecanu L; Greeson J; Papadopoulos V Bioorg Med Chem Lett; 2006 Dec; 16(24):6277-80. PubMed ID: 17049234 [TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR studies on natural acetylcholinesterase inhibitors of Sarcococca saligna by comparative molecular field analysis (CoMFA). Zaheer-ul-Haq ; Wellenzohn B; Tonmunphean S; Khalid A; Choudhary MI; Rode BM Bioorg Med Chem Lett; 2003 Dec; 13(24):4375-80. PubMed ID: 14643329 [TBL] [Abstract][Full Text] [Related]
17. Receptor-based modeling and 3D-QSAR for a quantitative production of the butyrylcholinesterase inhibitors based on genetic algorithm. Zaheer-ul H; Uddin R; Yuan H; Petukhov PA; Choudhary MI; Madura JD J Chem Inf Model; 2008 May; 48(5):1092-103. PubMed ID: 18444627 [TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein inhibitors in coronary heart disease: Validated comparative QSAR modeling of N, N-disubstituted trifluoro-3-amino-2-propanols. Mondal C; Halder AK; Adhikari N; Jha T Comput Biol Med; 2013 Oct; 43(10):1545-55. PubMed ID: 24034746 [TBL] [Abstract][Full Text] [Related]
19. Comparative QSAR studies on peptide deformylase inhibitors. Lee JY; Doddareddy MR; Cho YS; Choo H; Koh HY; Kang JH; No KT; Pae AN J Mol Model; 2007 May; 13(5):543-58. PubMed ID: 17333308 [TBL] [Abstract][Full Text] [Related]
20. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors. Dowlati Beirami A; Hajimahdi Z; Zarghi A J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]